Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,350 | 39,977 | 38,988 | 42,634 | 13,855 |
| Marketable Securities | 11 | 22 | 22 | 49 | 101 |
| Receivables | 10,132 | 135 | 2,834 | 1,298 | N/A |
| Other current assets | 1,211 | 2,595 | 2,467 | 3,552 | 0 |
| TOTAL | $54,188 | $43,461 | $45,399 | $48,986 | $14,561 |
| Non-Current Assets | |||||
| PPE Net | 3 | 4 | 5 | 6 | 7 |
| TOTAL | $3 | $4 | $5 | $6 | $7 |
| Total Assets | $54,191 | $43,465 | $45,404 | $48,992 | $14,568 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,890 | 2,323 | 2,221 | 1,069 | 1,468 |
| Accrued Expenses | 1,926 | 3,438 | 1,933 | 1,684 | 1,223 |
| Other current liabilities | 93 | N/A | N/A | N/A | N/A |
| TOTAL | $3,909 | $5,761 | $4,154 | $2,753 | $2,691 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,909 | $5,761 | $4,154 | $2,753 | $2,691 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,638 | 21,008 | 20,952 | 20,948 | 20,807 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -76,671 | -82,232 | -77,271 | -71,480 | -105,421 |
| TOTAL | $50,282 | $37,704 | $41,250 | $46,239 | $11,877 |
| Total Liabilities And Equity | $54,191 | $43,465 | $45,404 | $48,992 | $14,568 |